- Home
- Publications
- Publication Search
- Publication Details
Title
Phosphorylation of LRRK2: from kinase to substrate
Authors
Keywords
-
Journal
BIOCHEMICAL SOCIETY TRANSACTIONS
Volume 40, Issue 5, Pages 1102-1110
Publisher
Portland Press Ltd.
Online
2012-11-09
DOI
10.1042/bst20120128
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Kinases as Targets for Parkinson's Disease: From Genetics to Therapy
- (2012) Renee Vancraenenbroeck et al. CNS & Neurological Disorders-Drug Targets
- Expression of leucine-rich repeat kinase 2 (LRRK2) inhibits the processing of uMtCK to induce cell death in a cell culture model system
- (2011) Jie Cui et al. BIOSCIENCE REPORTS
- LRRK2 directly phosphorylates Akt1 as a possible physiological substrate: Impairment of the kinase activity by Parkinson's disease-associated mutations
- (2011) Etsuro Ohta et al. FEBS LETTERS
- Leucine-rich repeat kinase 2 regulates autophagy through a calcium-dependent pathway involving NAADP
- (2011) Patricia Gómez-Suaga et al. HUMAN MOLECULAR GENETICS
- Autophosphorylation in the Leucine-Rich Repeat Kinase 2 (LRRK2) GTPase Domain Modifies Kinase and GTP-Binding Activities
- (2011) Philip J. Webber et al. JOURNAL OF MOLECULAR BIOLOGY
- Phosphorylation of LRRK2 serines 955 and 973 is disrupted by Parkinson’s disease mutations and LRRK2 pharmacological inhibition
- (2011) Elizabeth A. Doggett et al. JOURNAL OF NEUROCHEMISTRY
- Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2
- (2011) Xianming Deng et al. Nature Chemical Biology
- The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease
- (2011) Zhihua Liu et al. NATURE IMMUNOLOGY
- On the Road to Leucine-Rich Repeat Kinase 2 Signalling: Evidence from Cellular and in vivo Studies
- (2011) V. Daniëls et al. NEUROSIGNALS
- Phosphorylation-Dependent 14-3-3 Binding to LRRK2 Is Impaired by Common Mutations of Familial Parkinson's Disease
- (2011) Xianting Li et al. PLoS One
- LRRK2 Kinase Activity Is Dependent on LRRK2 GTP Binding Capacity but Independent of LRRK2 GTP Binding
- (2011) Jean-Marc Taymans et al. PLoS One
- Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser910/Ser935, disruption of 14-3-3 binding and altered cytoplasmic localization
- (2010) Nicolas Dzamko et al. BIOCHEMICAL JOURNAL
- 14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization
- (2010) R. Jeremy Nichols et al. BIOCHEMICAL JOURNAL
- Membrane Localization of LRRK2 Is Associated with Increased Formation of the Highly Active LRRK2 Dimer and Changes in Its Phosphorylation
- (2010) Zdenek Berger et al. BIOCHEMISTRY
- Mechanisms in dominant parkinsonism: The toxic triangle of LRRK2, α-synuclein, and tau
- (2010) Jean-Marc Taymans et al. BIOESSAYS
- Leucine-rich repeat kinase 2 induces α-synuclein expression via the extracellular signal-regulated kinase pathway
- (2010) Iria Carballo-Carbajal et al. CELLULAR SIGNALLING
- Reevaluation of Phosphorylation Sites in the Parkinson Disease-associated Leucine-rich Repeat Kinase 2
- (2010) Xiaojie Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MKK6 binds and regulates expression of Parkinson’s disease-related protein LRRK2
- (2010) Cindy H. Hsu et al. JOURNAL OF NEUROCHEMISTRY
- Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant
- (2010) Veronique Daniëls et al. JOURNAL OF NEUROCHEMISTRY
- LRRK2 G2019S Mutation Induces Dendrite Degeneration through Mislocalization and Phosphorylation of Tau by Recruiting Autoactivated GSK3
- (2010) C.-H. Lin et al. JOURNAL OF NEUROSCIENCE
- Phosphopeptide Analysis Reveals Two Discrete Clusters of Phosphorylation in the N-Terminus and the Roc Domain of the Parkinson-Disease Associated Protein Kinase LRRK2
- (2010) Christian Johannes Gloeckner et al. JOURNAL OF PROTEOME RESEARCH
- Heterodimerization of Lrrk1–Lrrk2: Implications for LRRK2-associated Parkinson disease
- (2010) Justus C. Dachsel et al. MECHANISMS OF AGEING AND DEVELOPMENT
- The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
- (2010) Mark R. Cookson NATURE REVIEWS NEUROSCIENCE
- LRRK2 and the Stress Response: Interaction with MKKs and JNK-Interacting Proteins
- (2010) C.H. Hsu et al. Neurodegenerative Diseases
- Identification and Characterization of a Leucine-Rich Repeat Kinase 2 (LRRK2) Consensus Phosphorylation Motif
- (2010) Pooja P. Pungaliya et al. PLoS One
- Signal Transduction Protein Array Analysis Links LRRK2 to Ste20 Kinases and PKC Zeta That Modulate Neuronal Plasticity
- (2010) Susanne Zach et al. PLoS One
- GTPase Activity Plays a Key Role in the Pathobiology of LRRK2
- (2010) Yulan Xiong et al. PLoS Genetics
- Leucine-Rich Repeat Kinase 2 Mutations and Parkinson's Disease: Three Questions
- (2009) Elisa Greggio et al. ASN Neuro
- The Parkinson’s disease kinase LRRK2 autophosphorylates its GTPase domain at multiple sites
- (2009) Elisa Greggio et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson's disease
- (2009) R. Jeremy Nichols et al. BIOCHEMICAL JOURNAL
- Identification of the Autophosphorylation Sites of LRRK2
- (2009) Shogo Kamikawaji et al. BIOCHEMISTRY
- Molecular pathogenesis of Parkinson disease: insights from genetic studies
- (2009) Thomas Gasser EXPERT REVIEWS IN MOLECULAR MEDICINE
- Leucine-rich repeat kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a Drosophila melanogaster model of Parkinson's disease
- (2009) K. Venderova et al. HUMAN MOLECULAR GENETICS
- Caenorhabditits elegansLRK-1 and PINK-1 Act Antagonistically in Stress Response and Neurite Outgrowth
- (2009) Julia Sämann et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dependence of Leucine-rich Repeat Kinase 2 (LRRK2) Kinase Activity on Dimerization
- (2009) Saurabh Sen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Parkinson disease-associated protein kinase LRRK2 exhibits MAPKKK activity and phosphorylates MKK3/6 and MKK4/7,in vitro
- (2009) Christian Johannes Gloeckner et al. JOURNAL OF NEUROCHEMISTRY
- Homo- and heterodimerization of ROCO kinases: LRRK2 kinase inhibition by the LRRK2 ROCO fragment
- (2009) Christian L. Klein et al. JOURNAL OF NEUROCHEMISTRY
- The WD40 Domain Is Required for LRRK2 Neurotoxicity
- (2009) Nathan D. Jorgensen et al. PLoS One
- The Parkinson Disease-associated Leucine-rich Repeat Kinase 2 (LRRK2) Is a Dimer That Undergoes Intramolecular Autophosphorylation
- (2008) Elisa Greggio et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Wild-type LRRK2 but not its mutant attenuates stress-induced cell death via ERK pathway
- (2008) Anthony K.F. Liou et al. NEUROBIOLOGY OF DISEASE
- Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase
- (2008) J. Deng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started